Pharmaceutical Industry News Archive - December 2013
Get news by email or subscribe to our news feeds.
December 2, 2013
- Report: Big Data Can Change Patient Recruitment
- Shire in Generic Adderall XR Deal
- Janssen: Xeplion Effective in Patients with Schizophrenia
- Healios, Dainippon Sumitomo Pharma in $50.6M Deal
- Forest Announces Plans to Streamline Operations
- Forest to Buy U.S. Marketing Rights to Merck's Saphris
- Lilly, Boehringer Ingelheim Launch Diabetes Survey
- Pharma Should Factor Medication Adherence Into Drug Development
- Elton John AIDS Foundation and Mylan Give $1 Million to Nigeria for the Elimination of Mother-to-Child Transmission of HIV
December 3, 2013
- Obesity Drug Highlights Novo Nordisk Presentation
- Pharma Firms Investing More in New Products but Returns Wane
- Celgene, OncoMed in $177M Cancer Stem Cell Deal
- Analysts: New Cholesterol Treatment Guidelines Present Challenges
- Medical Advertising Hall of Fame elects Thomas Domanico, Carroll Dowden, and Clive Lewis, and gives Service to Industry Award to Barbara Pritchard
- Grant to Study Impact of Quality and Price Transparency on Consumer Choice
- PrimeraDx Receives 510(k) Clearance from FDA
- Roche Launches Cobas P 480 Instrument
- Cochlear Announces the FDA Clearance of the Baha 4 Attract System
- Physicians Interactive Expands Access to CME Content
- Fake it until you become it: Lessons from the Healthcare Businesswomen’s Association leadership conference
- Advanced Clinical Selects Veeva Vault eTMF as Standard for New eTMF Services
- VeriMed Launches Radar
December 4, 2013
- Osiris CEO Resigns, Shares Slip
- Boehringer Ingelheim Venture Fund to Invest $130M in Boston Area
- Teva In-Focus: A Webinar Series for the Investment Community Focusing on Teva’s R&D Activities
- AstraZeneca Gets $76M in Prilosec Case
- Teva, Takeda in Copaxone Deal in Japan
- 'Dancing with the Stars' Star Partners With Teva
- CTI, GKV Reach Agreement on Pixuvri Pricing
- Harvard Bioscience Realigning, Cutting 13% of Jobs
- PACIFIC Communications Named Agency of Record for SkinMedica
- Ambit Biosciences Falls on Slower Path for Drug
- Pfizer Expands Clinical Trial Data Access Policy
- Rho Principal Programmer Named Conference Chair of Southeastern SAS User’s Group for 2016 Term
- Kenco Appoints Kevin Fletcher Senior Vice President of Transportation Services
- Hemispherx Biopharma Appoints New Chief Financial and Chief Accounting Officers
- Lophius Biosciences Appoints Dr. Robert Phelps as Director Business Operations
- Celator Pharmaceuticals Announces Appointment of Derek Miller as Chief Business Officer
- Oxford Immunotec Global PLC Announces Appointment of Herm Rosenman to the Board of Directors
- Adaptimmune appoints Dr Jonathan Knowles as Chairman of the Board
- OXiGENE Appoints Frederick W. Driscoll to Its Board of Directors
- CereSpir Incorporated Appoints Richard Margolin, MD, as Vice President, Clinical Development
December 5, 2013
- Research Indicates that Physicians Prefer Digital Media
- Doctors Prefer Digital Media to In-Person Sales Reps
- Arca Can Start Human Testing of Heart Drug Gencaro
- Chemocentryx Shares Edge Higher
- Crossix POC Impact Increases Campaign Measurement Accuracy
- Novo Nordisk Study: Only 29% of Diabetics Say Doc Asks for Their Input
- Report: Approval of First Biosimilar Monoclonal Antibody In Europe Has Major Implications
- Frost & Sullivan: Minimally Invasive Approach Boosts Demand for Endoscopy Devices in Australia, South Korea and Southeast Asia
- Ventana Receives FDA Clearance
- Melinta Therapeutics Bolsters Executive Team with Appointment of Paul Estrem as Chief Financial Officer
- Celerion Appoints John Horkulak as Executive Director, Eurasian Site Operations
- Inventiv Health Hires Senior Life Sciences Executive to Oversee Expansion of Multi-Faceted Operations in India
- Vision-Sciences Promotes Howard Zauberma
- Cho Named President of Harlan Korea
- Benchworks Promotes Thompson, Jamison
- Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors
- Melinta Therapeutics Appoints Sue Cammarata, M.D. as Chief Medical Officer
- INC Research Appoints Gregory M. Hockel, PhD to Lead Regulatory Consulting Practice
- Arno Therapeutics Adds Steven Rubin, EVP of OPKO Health, Inc., as Board Observer
- Ad-ventures in marketing VII
- Report: VC Funding in Life Sciences Falls Behind
- Mobile maze
December 6, 2013
- Celgene Rises As UBS Upgrades Shares to 'Buy'
- Novartis: Multiple Myeloma Drug Meets Phase III Endpoint
- GSK Launches Global Consortium
- EMA Starts In-Depth Review of Iclusig
- Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement
- Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test
- Nearly Half of U.S. Adults Opted for Flu Vaccine in 2012
- Nearly Half of U.S. Adults Opted for Flu Vaccine
- New Information on Defined Contribution Health Benefits Published
- Saint Luke's Heart Attack Survival Rates are Better than 98 Percent of Hospitals in the Nation
- Crossix POC Impact Delivers Campaign Measurement Accuracy
- Glaxo and its transparency commitment
- The Last Word - How “The best thing that could ever happen to you” – happened to me
- To the Point - Technical difficulties
- Assessing future loss of exclusivity scenarios
- Facts and Figures - November 2013
- Most-recognized brands, Oncology and Hematology, November 2013
December 9, 2013
- Ceiba Solutions Launches iSwarm Windows Phone 8 App
- US Approves Breakthrough Hepatitis C Drug
- App Allows Users to Sift through Social Media Content
- Novartis supplies MenB vaccine, Bexsero®, to Princeton University to help protect students from potentially deadly outbreak
- OIG Subpoenas United Therapeutics Over Marketing
- Publicis Groupe Broadens Healthcare Expertise
- Acura: FDA to Review Painkiller Study
- Sanofi US Launches Second Innovation Challenge
- Janssen Starts Drug Donation Program for HIV Treatment-Experienced Children
- Publicis Looks to Verilogue to Heighten Exceptionality via Acquisition
- Practical advice for pharma SEO
- PCPs facing e-prescribing challenges
- More than half now write e-prescriptions
- Internet resources support consumer decision making
- The importance of creative endurance in developing winning ads
December 10, 2013
- Teva Provides Two Scenarios for Outlook
- Novo Nordisk Reported to the Police By the Danish Financial Supervisory Authority for Violating Disclosure Obligation
- Novo Nordisk Reported to Police for Breaching Disclosure Rules
- Eisai Announces New Partnership with Esteve
- Report: Wearable Medical Devices Market is Expected to Reach $5.8B Globally in 2019
- Bristol-Myers Squibb Foundation Announces Two Grants to Fund Cancer Nursing Centers
- American Medical Systems Receives FDA 510(k) Clearance
- Anavex Appoints Clinical Design Expert to Scientific Advisory Board
- Hiroharu Okochi Named New President of Harlan Japan
- Nuevolution Appoints Ton Berkien as Chief Business Officer
December 11, 2013
- Activist Hedge Fund Seeks Higher Bid in Pharmaceutical Merger
- Actavis Announces Tentative Agreement Related to Asacol Patent Challenge
- Savient to Sell Substantially All Assets to Crealta Pharmaceuticals
- Study: Long-term Use of Common Heartburn and Ulcer Medications Linked to Vitamin B12 Deficiency
- CVS Caremark, Cardinal Health to Form Joint Generic Venture
- GSK Invests $328M in Manufacturing, Science
- Mobius Imaging Receives ISO 13485 Certification
- Report: Antimicrobial Coatings Market Worth $2.9 Billion by 2018
- Medimmune, the Johns Hopkins University Announce 5-Year, $6.5M Collaboration
- Johnson & Johnson Innovation Establishes Network of Partnering Offices in UK Life Sciences Clusters
- Prescription Drug Abusers, Sellers Now on VeriMed's Radar
- Report Names Top 10 Health Industry Issues for 2014
- CMI/Compas: PCPs, Pharma Should Let Sunshine Act In
- Report Identifies Top 10 Industry Concerns for 2014
- FDA Approves First Generic Versions of Antidepressant Drug Cymbalta
December 12, 2013
- Vivus, Sanofi in Avanafil Pact
- Study: GSK's FluLaval Vaccine Effective in Kids
- FDA Approves First Generic Versions of Cymbalta
- Emergent BioSolutions to Buy Cangene for $222M
- Ethicon Receives 510(K) Clearance for Harmonic Focus+ Shears
- Abstral Launched in Japan
- Susan Duffy Joins McCann RCW As President
- For Engagement, DIG Looks toward Future
December 13, 2013
- OIG Subpoenas Insys Therapeutics
- Merck KGaA: Allergopharma Plans to Invest $55M in Production Facility
- Doximity Takes on Physician Shortage with Launch of Talent Finder
- FDA Advisory Panel Votes Favorably on the Boston Scientific WATCHMAN Left Atrial Appendage Closure Device
- St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve
- New FDA approved pre-surgical treatment for cleft lip/palate
- Psychiatrists Less Likely to Accept Insurance Than Other Physicians
- Congress Moves Closer To Changing How Medicare Pays Doctors
- New Survey Reveals Employers' Plans, Preferences and Challenges Related to Private and Public Health Insurance Exchanges
- AMN Healthcare Survey: Hospital Executives See Continued Shortage of Physicians, Nurses and Advanced Practitioners
- PwC's Health Research Institute Identifies the Top 10 Health Industry Issues for 2014
- FDA Allows Marketing of First Device to Relieve Migraine Headache Pain
December 16, 2013
- GlaxoSmithKline Raising Stake in India
- Endo to Acquire Specialty Pharmaceutical Company NuPathe
- Hemispherx Biopharma Accelerates Program to Evaluate Ampligen/FluMist
- AcelRx and Grunenthal Announce Collaboration for EU Commercialization of Zalviso
- Apricus Expands Exclusive License Agreement to Market Vitaros
- EMD Serono's Redesigned Fertility Pen Available for Distribution in U.S.
- Doximity's Talent Finder Grants Employment Opportunities
December 17, 2013
- Lonza Amends Contract with Orange Business Services
- Trinity Pharma Raises $15M for Life Sciences Cloud Analytics
- GlaxoSmithKline to Change the Way it Markets Drugs
- Biogen Idec, Samsun BIoepis in Biosimilar Deal
- Boston Scientific Announces CE Mark Approval
- Report: Continuous Glucose Monitoring Market will Reach $568.5 Million Globally by 2020
- Almiral to Buy Aqua Pharmaceuticals for Up to $380M
- Evotec, Yale University to Collaborate on Cancer Therapy
- Corgenix Announces Filing of 510(k) Premarket Notification for FDA Clearance of TxBCardio Assay
- Digitas Health Appoints SVP of Social Strategy
- Pfizer Settles Viagra Patent Litigation With Teva
- Lock Up Your Medicines to Protect Children and Teens This Holiday Season
December 18, 2013
- Hanmi Launches Generic Nexium
- French Regulators Back Zostavax Vaccination
- GSK, ViiV: Lupin Generic Does Not Infringe Trizivir Patent
- Mylan Settles Targretin Suit
- Ocera Therapeutics, Roche in Discovery Deal
- Study: MCC Firms Get $100M From Pharma
- Branded or Generic? Adults Share Preferences in Study
December 19, 2013
- AstraZeneca to Buy BMS' Diabetes Stake for $4.1B
- ECRI Institute Helps Hospitals Address Joint Commission's 2014 Alarm Safety Goal
- Forest: New Fetzima Launched in U.S.
- Judicial Watch: Massive Health Insurance Policy Cancellations Resulting From Obamacare Mandates
- Sandoz Begins Phase III Clinical Trial for Biosimilar Adalimumab
- Algeta Board Backs Bayer $2.9B Buy Offer
- Pfizer Settles Viagra Patent Litigation With Teva
- Counterfeiters and Illicit Drug Smugglers Using Canada to Sell Fake Meds
- Report: Health R&D Spending Moves Slowly Upward
- HealthSTAR Communications Launches New Subsidiary
December 20, 2013
- Jazz Pharmaceuticals to Buy Gentium for $1B
- FDA Sends Amarin Letter over Webcast Invitation
- FDA Sends Letter to Covis Over Physician Letter
- Merck Launches Weight Managment Intervention Business
- Philips receives FDA clearance for First-Ever Spectral Breast Density Measurement Application
- Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe
- Sobi to Take Direct Responsibility for Orfadin in the US, Canada and Latin America
- Study: Most Workers Satisfied With Pay-Benefits Balance
- The Last Word - Be credible – or be cooked
- ACOs rising: Strategic opportunities in the evolution of accountable care organizations
- Facts & Figures - December 2013
- Consumer shift offers opportunity to pharma
- Most-recognized brands: Anti-infectives, December 2013
December 23, 2013
- EU OKs Erbitix Labeling
- FDA Allows Marketing of New Stent for Treating Pseudocysts of the Pancreas
- Ariad Resumes Selling Iclusig
- Rubicon Genomics Reports Surge In 2013 Sales Of Its Nucleic Acid Library Prep Kits
- Brazil's National Health System Currently Provides Coverage for 22 Drugs that are Distributed Free of Charge to Over 300,000 HIV-Infected Patients
- Shifting sands
- Healthcare Agency Roundtable 2013
- Online marketplace for physicians
- Cegedim launches social site for docs
- Facts and figures, Interactive Digital Marketing, December 2013
- Mobile usage transforming doc/patient relations
- Ad agency people on the move, December 2013
- Palio+Ignite names new leaders
- Publicis acquires Heartbeat Ideas
- BMS makes changes to senior management team
- People on the move, December 2013
- New emerging markets leader for Lilly
- Resolutions for 2014
- Recall of Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
December 26, 2013
- Hi-Tech Settles Texas Pricing Probe for $25M
- Report: Drug Device Combination Products Market Expected to Reach $115.1B Globally in 2019
- Warner Chilcott Files ANDA for NuvaRing
- Dainippon Sumitomo Pharma Sets Up Oncology Clinical Development Unit
- Sagent Pharmaceuticals Launches Octreotide Acetate Injection
- Reports Indicate Co-Managed Care Popular Among Older Adults with Low Back Pain
- Small Business Health Insurance Alternatives
- Hospital-Diagnosed Maternal Infections Linked to Increased Autism Risk
December 27, 2013
- ANI Pharmaceuticals Buys 31 Generic Drug Products from Teva
- Astellas, Immuno-Biological Laboratories in Silkworm Deal
- Shire Extends Tender Offer for ViroPharma
- Report: Focus on Compliance Reduces Risk for Payers in the Medicare and Medicaid Markets
